Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Immunology, Immunotherapy
Published in: Cancer Immunology, Immunotherapy 5/1998

01-07-1998 | ORIGINAL ARTICLE

γ-Ray irradiation induces B7.1 costimulatory molecule neoexpression in various murine tumor cells

Authors: Arnaud Morel, Nadine Fernandez, A. de La Coste, Hédi Haddada, Mireille Viguier, Barbara S. Polla, Bénédicte Antoine, A. Kahn

Published in: Cancer Immunology, Immunotherapy | Issue 5/1998

Login to get access
Metadata
Title
γ-Ray irradiation induces B7.1 costimulatory molecule neoexpression in various murine tumor cells
Authors
Arnaud Morel
Nadine Fernandez
A. de La Coste
Hédi Haddada
Mireille Viguier
Barbara S. Polla
Bénédicte Antoine
A. Kahn
Publication date
01-07-1998
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 5/1998
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s002620050488

Other articles of this Issue 5/1998

Cancer Immunology, Immunotherapy 5/1998 Go to the issue

REVIEW

A review of the association between interleukin-10 and human B-cell malignancies

ORIGINAL ARTICLE

Colon cancer cell vaccine prepared with replication-deficient vaccinia viruses encoding B7.1 and interleukin-2 induce antitumor response in syngeneic mice

ORIGINAL ARTICLE

Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy women

ORIGINAL ARTICLE

Stimulation of immune suppressive CD34+ cells from normal bone marrow by Lewis lung carcinoma tumors

ORIGINAL ARTICLE

Ex vivo activation of tumor-draining lymph node T cells reverses defects in signal transduction molecules

ORIGINAL ARTICLE

Adenoviral transduction of melanoma cells with B7-1: antitumor immunity and immunosuppressive factors
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits